Exos Asset Management’s Ingevity NGVT Stock Holding History

Exos Asset Management’s Portfolio NGVT Stock Details NGVT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2021 Q3	–	Sell	-342	Closed	-$28K	–	612
2021 Q2	$28K	Buy	+342	New	+$27.5K	0.01%	632

Other funds holding NGVT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

Boston Partners Boston, Massachusetts $95.5B AUM 28.4% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return

BBCM

Broad Bay Capital Management New York $1.18B AUM 65.45% 1-Year Est. Return

ICP

Inclusive Capital Partners San Francisco, California $26M AUM 22.24% 1-Year Est. Return

AAM

Ardevora Asset Management London, United Kingdom $1.12B AUM 26.09% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Exos Asset Management's NGVT Position: Q3 2021 in Review

Exos Asset Management sold out of Ingevity (NGVT) in Q3 2021, closing a stake of 342 shares — an estimated $28K sold.

Exos Asset Management first reported a position in NGVT in Q2 2021 and held it in 1 quarter. The position peaked at $28K in Q2 2021. 277 funds tracked by Wall St. Rank hold NGVT as of Q3 2021.

Exos Asset Management reported no remaining Ingevity position as of Q3 2021 after selling out during the quarter.
Exos Asset Management sold 342 Ingevity shares in Q3 2021, an estimated $28K.
Exos Asset Management first reported a position in Ingevity in Q2 2021 and held it in 1 quarter.
Exos Asset Management's Ingevity position peaked at $28K in Q2 2021.
277 funds tracked by Wall St. Rank held Ingevity as of Q3 2021.

Based on Exos Asset Management's 13F filing for Q3 2021, filed 25 Oct 2021.